Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin.

Frias JP, Wynne AG, Matyjaszek-Matuszek B, Bartaskova D, Cox DA, Woodward B, Li YG, Tham LS, Milicevic Z.

Diabetes Obes Metab. 2019 Sep;21(9):2048-2057. doi: 10.1111/dom.13764. Epub 2019 Jun 3.

PMID:
31050143
2.

Control of pancreatic β-cell bioenergetics.

Affourtit C, Alberts B, Barlow J, Carré JE, Wynne AG.

Biochem Soc Trans. 2018 Jun 19;46(3):555-564. doi: 10.1042/BST20170505. Epub 2018 Apr 17. Review.

PMID:
29666215
3.

The effectiveness of smoking cessation, physical activity/diet and alcohol reduction interventions delivered by mobile phones for the prevention of non-communicable diseases: A systematic review of randomised controlled trials.

Palmer M, Sutherland J, Barnard S, Wynne A, Rezel E, Doel A, Grigsby-Duffy L, Edwards S, Russell S, Hotopf E, Perel P, Free C.

PLoS One. 2018 Jan 5;13(1):e0189801. doi: 10.1371/journal.pone.0189801. eCollection 2018. Review.

4.

Health-related quality of life and tuberculosis: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Health Qual Life Outcomes. 2015 May 27;13:65. doi: 10.1186/s12955-015-0250-4.

5.

The impact of tuberculosis on health utility: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Qual Life Res. 2015 Jun;24(6):1337-49. doi: 10.1007/s11136-014-0858-6. Epub 2014 Nov 13.

PMID:
25391490
6.

Tuberculosis and human immunodeficiency virus: exploring stigma in a community in western Uganda.

Wynne A, Richter S, Jhangri GS, Alibhai A, Rubaale T, Kipp W.

AIDS Care. 2014;26(8):940-6. doi: 10.1080/09540121.2014.882488. Epub 2014 Feb 13.

PMID:
24521055
7.

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.

Hausenloy DJ, Whittington HJ, Wynne AM, Begum SS, Theodorou L, Riksen N, Mocanu MM, Yellon DM.

Cardiovasc Diabetol. 2013 Oct 22;12:154. doi: 10.1186/1475-2840-12-154.

8.

Molecular evolution of a novel marsupial S100 protein (S100A19) which is expressed at specific stages of mammary gland and gut development.

Kwek JH, Wynne A, Lefèvre C, Familari M, Nicholas KR, Sharp JA.

Mol Phylogenet Evol. 2013 Oct;69(1):4-16. doi: 10.1016/j.ympev.2013.05.005. Epub 2013 May 22.

PMID:
23707702
9.

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.

Hausenloy DJ, Wynne AM, Mocanu MM, Yellon DM.

J Cardiovasc Pharmacol Ther. 2013 May;18(3):263-9. doi: 10.1177/1074248412468945. Epub 2012 Dec 21.

PMID:
23263382
10.

Tuberculosis in the era of infection with the human immunodeficiency virus: assessment and comparison of community knowledge of both infections in rural Uganda.

Wynne A, Jhangri GS, Richter S, Alibhai A, Rubaale T, Kipp W.

BMC Int Health Hum Rights. 2012 Dec 20;12:36. doi: 10.1186/1472-698X-12-36.

11.
12.

Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System.

Wynne A, Kanwar RK, Khanna R, Kanwar JR.

Curr Neuropharmacol. 2010 Sep;8(3):268-75. doi: 10.2174/157015910792246191.

13.

Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injury.

Smith CC, Lim SY, Wynne AM, Sivaraman V, Davidson SM, Mocanu MM, Hausenloy DJ, Yellon DM.

J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):63-71. doi: 10.1177/1074248410382232. Epub 2010 Dec 23.

PMID:
21183727
14.

Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.

Smith CC, Dixon RA, Wynne AM, Theodorou L, Ong SG, Subrayan S, Davidson SM, Hausenloy DJ, Yellon DM.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1265-70. doi: 10.1152/ajpheart.00092.2010. Epub 2010 Jul 23.

15.

Protracted downregulation of CX3CR1 on microglia of aged mice after lipopolysaccharide challenge.

Wynne AM, Henry CJ, Huang Y, Cleland A, Godbout JP.

Brain Behav Immun. 2010 Oct;24(7):1190-201. doi: 10.1016/j.bbi.2010.05.011. Epub 2010 Jun 4.

16.

Ischaemic preconditioning and postconditioning do not affect adenosine A(1) and A (2A) receptor sensitivity.

Riksen NP, Wynne A, Yellon DM, Hausenloy DJ.

Cardiovasc Drugs Ther. 2009 Oct;23(5):415-7. doi: 10.1007/s10557-009-6196-1. No abstract available.

17.

Immune and behavioral consequences of microglial reactivity in the aged brain.

Wynne AM, Henry CJ, Godbout JP.

Integr Comp Biol. 2009 Sep;49(3):254-66. doi: 10.1093/icb/icp009. Epub 2009 Apr 23.

18.

Preconditioning the diabetic human myocardium.

Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM.

J Cell Mol Med. 2010 Jun;14(6B):1740-6. doi: 10.1111/j.1582-4934.2009.00796.x. Epub 2009 Jun 5.

19.

The cardioprotective actions of leptin are lost in the Zucker obese (fa/fa) rat.

Dixon RA, Davidson SM, Wynne AM, Yellon DM, Smith CC.

J Cardiovasc Pharmacol. 2009 Apr;53(4):311-7. doi: 10.1097/FJC.0b013e31819d6152.

PMID:
19390347
20.
21.

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.

Henry CJ, Huang Y, Wynne A, Hanke M, Himler J, Bailey MT, Sheridan JF, Godbout JP.

J Neuroinflammation. 2008 May 13;5:15. doi: 10.1186/1742-2094-5-15.

22.

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M.

Diabetes Care. 2008 Jul;31(7):1305-10. doi: 10.2337/dc07-2137. Epub 2008 Mar 25.

23.

Bullwhip neurons in the retina regulate the size and shape of the eye.

Fischer AJ, Ritchey ER, Scott MA, Wynne A.

Dev Biol. 2008 May 1;317(1):196-212. doi: 10.1016/j.ydbio.2008.02.023. Epub 2008 Feb 26.

24.

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.

Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM.

Basic Res Cardiol. 2008 May;103(3):274-84. Epub 2007 Dec 13.

PMID:
18080084
25.

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A.

Diabetes Obes Metab. 2009 Jan;11(1):27-32. Epub 2007 Oct 17.

PMID:
17941873
26.

Temporal changes in myocardial salvage kinases during reperfusion following ischemia: studies involving the cardioprotective adipocytokine apelin.

Smith CC, Mocanu MM, Bowen J, Wynne AM, Simpkin JC, Dixon RA, Cooper MB, Yellon DM.

Cardiovasc Drugs Ther. 2007 Dec;21(6):409-14.

PMID:
17924178
27.

Distributing questionnaires about smoking to patients: impact on general practitioners' recording of smoking advice.

Coleman T, Wilson A, Barrett S, Wynne A, Lewis S.

BMC Health Serv Res. 2007 Sep 24;7:153.

28.

Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.

Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC.

Basic Res Cardiol. 2007 Nov;102(6):518-28. Epub 2007 Aug 13.

PMID:
17694254
29.

Ischemic preconditioning targets the reperfusion phase.

Hausenloy DJ, Wynne AM, Yellon DM.

Basic Res Cardiol. 2007 Sep;102(5):445-52. Epub 2007 May 29.

PMID:
17530316
30.

Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects.

Smith CC, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM.

Br J Pharmacol. 2006 Sep;149(1):5-13. Epub 2006 Jul 17.

32.
33.

Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.

Hausenloy D, Wynne A, Duchen M, Yellon D.

Circulation. 2004 Apr 13;109(14):1714-7. Epub 2004 Apr 5.

PMID:
15066952
34.

In vitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracycline and Lactobacillus plantarum LPK.

Payne S, Gibson G, Wynne A, Hudspith B, Brostoff J, Tuohy K.

Curr Issues Intest Microbiol. 2003 Mar;4(1):1-8.

PMID:
12691257
35.

An effective, cosmetically acceptable, novel hydro-gel emollient for the management of dry skin conditions.

Wynne A, Whitefield M, Dixon AJ, Anderson S.

J Dermatolog Treat. 2002 Jun;13(2):61-6.

PMID:
12060503
36.

The effect of a model melanoidin mixture on faecal bacterial populations in vitro.

Ames JM, Wynne A, Hofmann A, Plos S, Gibson GR.

Br J Nutr. 1999 Dec;82(6):489-95.

PMID:
10690164
37.

Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection.

Thomas HI, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P.

J Clin Virol. 1999 Oct;14(2):107-18.

PMID:
10588453
38.

The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV.

Medicine (Baltimore). 1996 Mar;75(2):53-63.

39.

Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features.

Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA.

Clin Endocrinol (Oxf). 1995 Oct;43(4):479-90. Review.

PMID:
7586624
40.

Familial dysalbuminemic hyperthyroxinemia: cumulative experience in 29 consecutive patients.

Heufelder AE, Klee GG, Wynne AG, Gharib H.

Endocr Pract. 1995 Jan-Feb;1(1):4-8.

PMID:
15251607
41.

Nifedipine, but not verapamil, acutely elevates parathyroid hormone levels in premenopausal women.

Wynne AG, Romanski SA, Klee GG, Ory SJ, O'Fallon WM, Fitzpatrick LA.

Clin Endocrinol (Oxf). 1995 Jan;42(1):9-15.

PMID:
7889637
42.

Sledding trauma in a northeastern Ontario community.

Wynne AD, Bota GW, Rowe BH.

J Trauma. 1994 Nov;37(5):820-5.

PMID:
7966483
43.

Internal audit. Called to account.

Wynne A.

Health Serv J. 1994 Jul 28;104(5413):27. No abstract available.

PMID:
10136326
44.

Parathyroid carcinoma: clinical and pathologic features in 43 patients.

Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA.

Medicine (Baltimore). 1992 Jul;71(4):197-205. Review.

PMID:
1518393
45.

Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excess.

Wynne AG, Scheithauer BW, Young WF Jr, Kovacs K, Ebersold MJ, Horvath E.

Neurosurgery. 1992 Jun;30(6):919-23.

PMID:
1319562
46.

Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.

Wynne AG, Gharib H, Scheithauer BW, Davis DH, Freeman SL, Horvath E.

Am J Med. 1992 Jan;92(1):15-24.

PMID:
1346235
47.

Mnemonics in clinical endocrinology.

Wynne AG, Fitzpatrick LA.

Hosp Pract (Off Ed). 1991 May 30;26(5A):23-9. No abstract available.

PMID:
2033097
48.

Doing the impossible: managing ICU with no head nurse.

Martin J, Wynne AE, Pesce LM.

Nurs Manage. 1990 Mar;21(3):64L, 64N, 64P. No abstract available.

PMID:
2314768
50.

Supplemental Content

Support Center